Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis

Current Opinion in Hematology

Volumn 24, Issue 3, 2017, Pages 159-166

  Dulmovits, Brian M ^a   Hom, Jimmy ^a   Narla, Anupama ^b   Mohandas, Narla ^c   Blanc, Lionel ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK BLOOD CENTER   (United States)

Author keywords

cell differentiation; erythropoiesis; glucocorticoids; human erythroid progenitors; pomalidomide

Indexed keywords

CELL SURFACE MARKER; CYTOKINE; GLUCOCORTICOID; GROWTH FACTOR; POMALIDOMIDE; BIOLOGICAL MARKER; IMMUNOLOGIC FACTOR; THALIDOMIDE;

CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SELF-RENEWAL; COLONY FORMING UNIT; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; GENE EXPRESSION; GLOBIN GENE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPHENOTYPING; MEGAKARYOCYTE ERYTHROID PROGENITOR; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL SELF-RENEWAL; ANALOGS AND DERIVATIVES; ANEMIA; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE;

ANEMIA; ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF RENEWAL; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; GLUCOCORTICOIDS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; PHENOTYPE; THALIDOMIDE;

EID: 85009766687     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000328     Document Type: Review

References (68)

1. Doulatov S, Notta F, Laurenti E, Dick JE. Hematopoiesis: a human perspective. Cell Stem Cell 2012; 10:120-136.
2. Seita J, Weissman IL. Hematopoietic stem cell: self-renewal versus differ-entiation. Wiley Interdiscip Rev Syst Biol Med 2010; 2:640-653.
3. Dore LC, Crispino JD. Transcription factor networks in erythroid cell and megakaryocyte development. Blood 2011; 118:231-239.
4. Koury MJ. Abnormal erythropoiesis and the pathophysiology of chronic anemia. Blood Rev 2014; 28:49-66.
5. Adolfsson J, Mansson R, Buza-Vidas N, et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005; 121:295-306.
6. Mansson R, Hultquist A, Luc S, et al. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors. Immunity 2007; 26:407-419.
7. Yamamoto R, Morita Y, Ooehara J, et al. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell 2013; 154:1112-1126.
8. Mori Y, Chen JY, Pluvinage JV, et al. Prospective isolation of human erythroid lineage-committed progenitors. Proc Natl Acad Sci USA 2015; 112:9638-9643.
9. Psaila B, Barkas N, Iskander D, et al. Single-cell profiling of human mega-karyocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways. Genome Biol 2016; 17:83.
10. Notta F, Zandi S, Takayama N, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science 2016; 351: aab2116.
11. Koury MJ. Tracking erythroid progenitor cells in times of need and times of plenty. Exp Hematol 2016; 44:653-663.
12. Vannucchi AM, Paoletti F, Linari S, et al. Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice. Blood 2000; 95:2559-2568.
13. Pronk CJ, Rossi DJ, Mansson R, et al. Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy. Cell Stem Cell 2007; 1:428-442.
14. Sanada C, Xavier-Ferrucio J, Lu YC, et al. Adult human megakaryocyte-erythroid progenitors are in the CD34+CD38mid fraction. Blood 2016; 128:923-933.
15. Flygare J, Rayon Estrada V, Shin C, et al. HIF1alpha synergizes with gluco-corticoids to promote BFU-E progenitor self-renewal. Blood 2011; 117:3435-3444.
16. Terszowski G, Waskow C, Conradt P, et al. Prospective isolation and global gene expression analysis of the erythrocyte colony-forming unit (CFU-E). Blood 2005; 105:1937-1945.
17. Li J, Hale J, Bhagia P, et al. Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. Blood 2014; 124:3636-3645.
18. Gao X, Lee HY, da Rocha EL, et al. TGF-beta inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors. Blood 2016; 128:2637-2641.
19. Xiang J, Wu DC, Chen Y, Paulson RF. In vitro culture of stress erythroid progenitors identifies distinct progenitor populations and analogous human progenitors. Blood 2015; 125:1803-1812.
20. Stadhouders R, Cico A, Stephen T, et al. Control of developmentally primed erythroid genes by combinatorial co-repressor actions. Nat Commun 2015; 6:8893.
21. Munugalavadla V, Kapur R. Role of c-Kit and erythropoietin receptor in erythropoiesis. Crit Rev Oncol Hematol 2005; 54:63-75.
22. Wu H, Klingmuller U, Acurio A, et al. Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci USA 1997; 94:1806-1810.
23. Sui X, Krantz SB, You M, Zhao Z. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoi-esis. Blood 1998; 92:1142-1149.
24. Tan BL, Hong L, Munugalavadla V, Kapur R. Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in Kit. Role for Src kinase pathway in Kit-induced cooperation with erythropoietin receptor. J Biol Chem 2003; 278:11686-11695.
25. Steinlein P, Wessely O, Meyer S, et al. Primary, self-renewing erythroid progenitors develop through activation of both tyrosine kinase and steroid hormone receptors. Curr Biol 1995; 5:191-204.
26. Papayannopoulou T, Brice M, Blau CA. Kit ligand in synergy with interleukin-3 amplifies the erythropoietin-independent, globin-synthesizing progeny of nor-mal human burst-forming units-erythroid in suspension cultures: physiologic implications. Blood 1993; 81:299-310.
27. Panzenbock B, Bartunek P, Mapara MY, Zenke M. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood 1998; 92:3658-3668.
28. Serke S, Huhn D. Effects of various recombinant human hemopoietic growth factors (rhEpo, rhG-CSF, rhGM-CSF, rhIl-3) on the growth of peripheral blood progenitor cells (BFU-E, CFU-GM). Blut 1990; 61:25-29.
29. Lewis JL, Marley SB, Blackett NM, et al. Interleukin 3 (IL-3), but not stem cell factor (SCF) increases self-renewal by human erythroid burst-forming units (BFU-E) in vitro. Cytokine 1998; 10:49-54.
30. Mizuguchi T, Kosaka M, Saito S. Activin A suppresses proliferation of interleukin-3-responsive granulocyte-macrophage colony-forming progenitors and stimulates proliferation and differentiation of interleukin-3-responsive erythroid burst-forming progenitors in the peripheral blood. Blood 1993; 81:2891-2897.
31. Broudy VC. Stem cell factor and hematopoiesis. Blood 1997; 90:1345-1364.
32. Nishinakamura R, Nakayama N, Hirabayashi Y, et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity 1995; 2:211-222.
33. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83:59-67.
34. Haas N, Riedt T, Labbaf Z, et al. Kit transduced signals counteract erythroid maturation by MAPK-dependent modulation of erythropoietin signaling and apoptosis induction in mouse fetal liver. Cell Death Differ 2015; 22:790-800.
35. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990; 248:378-381.
36. Kelley LL, Koury MJ, Bondurant MC, et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 1993; 82:2340-2352.
37. De Maria R, Testa U, Luchetti L, et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 1999; 93:796-803.
38. Bresnick EH, Lee HY, Fujiwara T, et al. GATA switches as developmental drivers. J Biol Chem 2010; 285:31087-31093.
39. Briegel K, Lim KC, Plank C, et al. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. Genes Dev 1993; 7:1097-1109.
40. Huang Z, Dore LC, Li Z, et al. GATA-2 reinforces megakaryocyte development in the absence of GATA-1. Mol Cell Biol 2009; 29:5168-5180.
41. Ikonomi P, Rivera CE, Riordan M, et al. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation. Exp Hematol 2000; 28:1423-1431.
42. Back J, Dierich A, Bronn C, et al. 1 determines the self-renewal capacity of erythroid progenitor cells. Blood 2004; 103:3615-3623.
43. Fisher RC, Slayton WB, Chien C, et al. PU.1 supports proliferation of immature erythroid progenitors. Leuk Res 2004; 28:83-89.
44. Zhang L, Prak L, Rayon-Estrada V, et al. ZFP36L2 is required for self-renewal of early burst-forming unit erythroid progenitors. Nature 2013; 499:92-96.
45. Copley MR, Babovic S, Benz C, et al. The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat Cell Biol 2013; 15:916-925.
46. Rowe RG, Wang LD, Coma S, et al. Developmental regulation of myeloer-ythroid progenitor function by the Lin28b-let-7-Hmga2 axis. J Exp Med 2016; 213:1497-1512.
47. Rich IN, Kubanek B. The ontogeny of erythropoiesis in the mouse detected by the erythroid colony-forming technique. I. Hepatic and maternal erythropoi-esis. J Embryol Exp Morphol 1979; 50:57-74.
48. Lee YT, de Vasconcellos JF, Yuan J, et al. LIN28B-mediated expression of fetal hemoglobin and production of fetal-like erythrocytes from adult human erythroblasts ex vivo. Blood 2013; 122:1034-1041.
49. Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 2008; 112:470-478.
50. Giger KM, Kalfa TA. Phylogenetic and ontogenetic view of erythroblastic islands. Biomed Res Int 2015; 2015:873628.
51. Hom J, Dulmovits BM, Mohandas N, Blanc L. The erythroblastic island as an emerging paradigm in the anemia of inflammation. Immunol Res 2015; 63:75-89.
52. Chow A, Huggins M, Ahmed J, et al.CD169(+) macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med 2013; 19:429-436.
53. Rhodes MM, Kopsombut P, Bondurant MC, et al. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin. Blood 2008; 111:1700-1708.
54. Means RT Jr. Pure red cell aplasia. Blood 2016; 128:2504-2509.
55. Narla A, Vlachos A, Nathan DG. Diamond-Blackfan anemia treatment: past, present, and future. Semin Hematol 2011; 48:117-123.
56. Ellis SR, Lipton JM. Diamond-Blackfan anemia: a disorder of red blood cell development. Curr Top Dev Biol 2008; 82:217-241.
57. Sankaran VG, Ghazvinian R, Do R, et al. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest 2012; 122:2439-2443.
58. Ludwig LS, Gazda HT, Eng JC, et al. Altered translation of GATA1 in Diamond-Blackfan anemia. Nat Med 2014; 20:748-753.
59. Dussiot M, Maciel TT, Fricot A, et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia. Nat Med 2014; 20:398-407.
60. Suragani RN, Cadena SM, Cawley SM, et al. Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med 2014; 20:408-414.
61. Chan HS, Saunders EF, Freedman MH. Diamond-Blackfan syndrome. II. In vitro corticosteroid effect on erythropoiesis. Pediatr Res 1982; 16:477-478.
62. Vignjevic S, Budec M, Markovic D, et al. Glucocorticoid receptor mediates the expansion of splenic late erythroid progenitors during chronic psychological stress. J Physiol Pharmacol 2015; 66:91-100.
63. Lee HY, Gao X, Barrasa MI, et al. PPAR-alpha and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal. Nature 2015; 522:474-477.
64. Fibach E, Manor D, Oppenheim A, Rachmilewitz EA. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989; 73: 100-103.
65. Narla A, Dutt S, McAuley JR, et al. Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis. Blood 2011; 118:2296-2304.
66. Dulmovits BM, Appiah-Kubi AO, Papoin J, et al. Pomalidomide reverses gamma-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors. Blood 2016; 127:1481-1492.
67. Papayannopoulou TH, Brice M, Stamatoyannopoulos G. Stimulation of fetal hemoglobin synthesis in bone marrow cultures from adult individuals. Proc Natl Acad Sci USA 1976; 73:2033-2037.
68. Stamatoyannopoulos G, Nakamoto B, Kurachi S, Papayannopoulou T. Direct evidence for interaction between human erythroid progenitor cells and a hemoglobin switching activity present in fetal sheep serum. Proc Natl Acad Sci USA 1983; 80:5650-5654.